finance.yahoo.com Β·
prenetics global q1 earnings call 190530158
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedPrenetics Global's Q1 earnings show strong growth driven by the IM8 supplement brand, with high subscription revenue and raised guidance. The company is a direct-to-consumer health supplement firm; the commercial mechanism is demand_spike for its own products, not a broad sector shift. Impact is company-specific, not global or regional.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources β not direct quotes from the publisher.
- Q1 2026 revenue $36M, +334% YoY from $8.3M
- IM8 supplement brand generated $33.8M revenue
- 93% of IM8 revenue from subscriptions, 82k active subscribers
- FY2026 IM8 revenue guidance raised to $190M-$210M
- Consolidated gross margin 64.8%